PubRank

C Schneeberger

Author PubWeight™ 27.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosomes Cancer 1994 1.27
2 Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines. Breast Cancer Res Treat 1999 1.15
3 Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women. Hum Reprod 2003 1.11
4 Estrogen-metabolizing gene polymorphisms and age at natural menopause in Caucasian women. Hum Reprod 2005 1.02
5 Human cervical ripening is associated with an increase in cervical inducible nitric oxide synthase expression. Biol Reprod 1999 0.99
6 Quantitative determination of gene expression by competitive reverse transcription-polymerase chain reaction in degraded RNA samples. Anal Biochem 1997 0.92
7 Genetic modelling of the estrogen metabolism as a risk factor of hormone-dependent disorders. Maturitas 2002 0.88
8 Patterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer. Int J Cancer 1994 0.88
9 Microdissection as a means to verify allelic imbalance in tumour biology samples. Anticancer Res 1996 0.87
10 Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade. Breast Cancer Res Treat 1999 0.87
11 Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines. Breast Cancer Res Treat 1996 0.85
12 Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer. Clin Cancer Res 1999 0.85
13 Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolation. Oncogene 1990 0.85
14 Endometrial nuclear receptor co-factors SRC-1 and N-CoR are increased in human endometrium during menstruation. Mol Hum Reprod 2002 0.82
15 Melatonin in postmenopausal females. Arch Gynecol Obstet 2000 0.82
16 Quantification of uPA receptor expression in human breast cancer cell lines by cRT-PCR. Breast Cancer Res Treat 1996 0.82
17 Genetic modeling of estrogen metabolism as a risk factor of hormone-dependent disorders. Maturitas 2002 0.81
18 Expression of endothelial (type III) nitric oxide synthase in cytotrophoblastic cell lines: regulation by hypoxia and inflammatory cytokines. Placenta 1998 0.81
19 Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma. Br J Cancer 1999 0.81
20 A polymorphism of the interleukin-1beta gene and idiopathic recurrent miscarriage. Fertil Steril 2001 0.81
21 A simple method for isolation of DNA from blood clots suited for use in PCR. Biotechniques 1993 0.80
22 Polymorphism 1558 C > T in the aromatase gene (CYP19A1) in low-grade endometrial stromal sarcoma. Eur J Gynaecol Oncol 2011 0.80
23 Detection of p53 point mutations in primary human vulvar cancer by PCR and temperature gradient gel electrophoresis. Gynecol Oncol 1997 0.79
24 Induction of inducible nitric oxide synthase expression in human secretory endometrium. Hum Reprod 1998 0.78
25 Rapid quantitative analysis of differential PCR products by high-performance liquid chromatography. Biotechniques 1993 0.78
26 Nitric oxide synthases in Kaposi's sarcoma are expressed predominantly by vessels and tissue macrophages. Lab Invest 1998 0.78
27 [The role of nitric oxide in reproduction]. Gynakol Geburtshilfliche Rundsch 1998 0.78
28 Oxytocin and vasopressin 1a receptor gene expression in the cycling or pregnant human uterus. Am J Obstet Gynecol 1998 0.77
29 Elevation of inducible nitric oxide synthase activity in human endometrium during menstruation. Biol Reprod 1999 0.77
30 Estrogen increases endothelial carbon monoxide, heme oxygenase 2, and carbon monoxide-derived cGMP by a receptor-mediated system. J Clin Endocrinol Metab 2001 0.76
31 [6-sulfatoxymelatonin in women with secondary amenorrhea]. Wien Klin Wochenschr 1997 0.76
32 Endocrinological disorders. Focusing on melatonin's interactions. Gynecol Obstet Invest 1999 0.76
33 Tryptophan hydroxylase gene polymorphism (A218C) and idiopathic recurrent miscarriage. Obstet Gynecol 2001 0.75
34 Calculated background elimination in quantifying nitric-oxide synthase enzyme activity. J Biochem Biophys Methods 2001 0.75
35 [Nursing care and AIDS]. Soins 1989 0.75
36 M3/M21 serum levels in women with adnexal masses and inflammatory diseases. Int J Cancer 1998 0.75
37 [Pharmacogenomics in gynecology. Replies to the Zurich Discussion Panel]. Gynakol Geburtshilfliche Rundsch 2003 0.75
38 Cathepsin D and PAI-1 expression in human head and neck cancer. Anticancer Res 1996 0.75
39 [Epidermal growth factor receptor in human breast cancer: correlation with steroid receptors, tumor stage, grading and menopausal status]. Geburtshilfe Frauenheilkd 1992 0.75
40 Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril 2001 0.75
41 [AIDS Stockholm, 6 nurses]. Rev Infirm 1988 0.75
42 Serum leptin in patients with vulvar cancer. Gynecol Oncol 2001 0.75
43 Estrogen does not induce the calcium-dependent nitric oxide synthase in cultured human uterine endothelial and myometrial smooth muscle cells. J Vasc Res 1997 0.75
44 [Blood culture]. Rev Infirm 1979 0.75